The present invention relates to a novel nano-emulsion formulation of vitamin D3 wherein the dosage comprising high dose of the vitamin D3 with improved drug absorption rate and bioavailability. Present disclosure also narrates about pharmaceutical dosage form of the vitamin D3, wherein vitamin D3 is in the form ...

The present incention relates to novel and improved nano-particulate pharmaceutical compositions of anticancer drugs, preferably paclitaxel, their derivatives or their analogues. This invention particularly relates to novel synergistic compositions of paclitaxel and crcumin along with protein albumin. The compositio...